Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: pure versus non-pure Cis.

CONCLUSIONS: Pure Cis and non-pure Cis are efficiently treated by BCG therapy combined with transurethral resection and/or radical cystectomy, with relatively low rate of progression. Cis type was the only significant predictor of progression. PMID: 31144485 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31144485?dopt=Abstract

Source: Minerva Urologica e Nefrologica - June 1, 2019 Category: Urology & Nephrology Tags: Minerva Urol Nefrol Source Type: research